1. Home
  2. SPRY vs ASIC Comparison

SPRY vs ASIC Comparison

Compare SPRY & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • ASIC
  • Stock Information
  • Founded
  • SPRY 2015
  • ASIC 2018
  • Country
  • SPRY United States
  • ASIC United States
  • Employees
  • SPRY N/A
  • ASIC N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • ASIC Property-Casualty Insurers
  • Sector
  • SPRY Health Care
  • ASIC Finance
  • Exchange
  • SPRY Nasdaq
  • ASIC Nasdaq
  • Market Cap
  • SPRY 1.1B
  • ASIC 1.1B
  • IPO Year
  • SPRY N/A
  • ASIC 2025
  • Fundamental
  • Price
  • SPRY $9.59
  • ASIC $18.95
  • Analyst Decision
  • SPRY Strong Buy
  • ASIC Strong Buy
  • Analyst Count
  • SPRY 4
  • ASIC 4
  • Target Price
  • SPRY $31.25
  • ASIC $25.50
  • AVG Volume (30 Days)
  • SPRY 2.5M
  • ASIC 87.1K
  • Earning Date
  • SPRY 11-10-2025
  • ASIC 10-22-2025
  • Dividend Yield
  • SPRY N/A
  • ASIC N/A
  • EPS Growth
  • SPRY N/A
  • ASIC 504.00
  • EPS
  • SPRY N/A
  • ASIC 0.17
  • Revenue
  • SPRY $142,772,000.00
  • ASIC $405,657,000.00
  • Revenue This Year
  • SPRY N/A
  • ASIC $14.58
  • Revenue Next Year
  • SPRY $193.13
  • ASIC $45.23
  • P/E Ratio
  • SPRY N/A
  • ASIC $109.44
  • Revenue Growth
  • SPRY 5459.66
  • ASIC 68.10
  • 52 Week Low
  • SPRY $6.66
  • ASIC $16.35
  • 52 Week High
  • SPRY $18.90
  • ASIC $25.30
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 57.78
  • ASIC N/A
  • Support Level
  • SPRY $6.66
  • ASIC N/A
  • Resistance Level
  • SPRY $7.40
  • ASIC N/A
  • Average True Range (ATR)
  • SPRY 0.80
  • ASIC 0.00
  • MACD
  • SPRY 0.21
  • ASIC 0.00
  • Stochastic Oscillator
  • SPRY 78.83
  • ASIC 0.00

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About ASIC Ategrity Specialty Insurance Company Holdings Common Stock

Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.

Share on Social Networks: